Movement Disorders

Cover image for Movement Disorders

Special Issue: Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease

2010

Volume 25, Issue S1

Pages S1–S179

Issue edited by: Fahn Stanley MD, Marder Karen MD, Côté Lucien MD, Reich Stephen G. MD

  1. Preface

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Preface (page S1)

      Stanley Fahn, Karen Marder and Lucien Côté

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.23029

  2. Introduction

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
  3. Pathogenesis and Implications for Neuroprotection

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Clinical implications of gene discovery in Parkinson's disease and parkinsonism (pages S15–S20)

      Christian Wider, Tatiana Foroud and Zbigniew K. Wszolek

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22723

    2. The behavior of α-synuclein in neurons (pages S21–S26)

      Doris L. Fortin, Venu M. Nemani, Ken Nakamura and Robert H. Edwards

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22722

    3. The role of parkin in familial and sporadic Parkinson's disease (pages S32–S39)

      Ted M. Dawson and Valina L. Dawson

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22798

    4. Protein degradation, aggregation, and misfolding (pages S49–S54)

      Ana Maria Cuervo, Esther S.P. Wong and Marta Martinez-Vicente

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22718

    5. Advances in environmental epidemiology (pages S58–S62)

      Caroline M. Tanner

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22721

  4. Status of the Central Role of Dopamine in PD

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Basal ganglia physiology and deep brain stimulation (pages S71–S75)

      Andres M. Lozano, Brian J. Snyder, Clement Hamani, William D. Hutchison and Jonathan O. Dostrovsky

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22714

  5. Evaluation of the Braak Staging Hyopthesis

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Evidence in favor of Braak staging of Parkinson's disease (pages S78–S82)

      Dennis W. Dickson, Hirotake Uchikado, Hiroshige Fujishiro and Yoshio Tsuboi

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22637

  6. New Developments in Testing, Diagnosis and Treatment of PD

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Parkinson's at risk syndrome: Can Parkinson's disease be predicted? (pages S89–S93)

      Matthew B. Stern and Andrew Siderowf

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22719

    2. Pain in Parkinson's disease (pages S98–S103)

      Blair Ford

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22716

    3. Sleep disturbances in Parkinson's disease (pages S117–S122)

      Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin and Karina Bienfait

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22788

    4. The nonmotor symptoms of Parkinson's disease—An overview (pages S123–S130)

      Shen-Yang Lim and Anthony E. Lang

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22786

  7. Preserving Function in PD

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Driving difficulties in Parkinson's disease (pages S136–S140)

      Matthew Rizzo, Ergun Y. Uc, Jeffrey Dawson, Steven Anderson and Robert Rodnitzky

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22791

    2. Enhancing neuroplasticity in the basal ganglia: The role of exercise in Parkinson's disease (pages S141–S145)

      Giselle M. Petzinger, Beth E. Fisher, Jon-Eric Van Leeuwen, Marta Vukovic, Garnik Akopian, Charlie K. Meshul, Daniel P. Holschneider, Angelo Nacca, John P. Walsh and Michael W. Jakowec

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22782

  8. Future Developments in Treatment of PD

    1. Top of page
    2. Preface
    3. Introduction
    4. Pathogenesis and Implications for Neuroprotection
    5. Status of the Central Role of Dopamine in PD
    6. Evaluation of the Braak Staging Hyopthesis
    7. New Developments in Testing, Diagnosis and Treatment of PD
    8. Preserving Function in PD
    9. Future Developments in Treatment of PD
    1. Mitochondrial therapies for Parkinson's disease (pages S155–S160)

      Bobby Thomas and M. Flint Beal

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22781

    2. Gene therapy for Parkinson's disease (pages S161–S173)

      Tomas Bjorklund and Jeffrey H. Kordower

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22785

    3. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease (pages S174–S179)

      Manolo Carta, Thomas Carlsson, Ana Muñoz, Deniz Kirik and Anders Björklund

      Version of Record online: 25 FEB 2010 | DOI: 10.1002/mds.22792

SEARCH

SEARCH BY CITATION